Boston Private Bank & Trust’s Charles River Laboratories CRL Stock Holding History

Boston Private Bank & Trust’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$28K	Hold	350	–	–	﹤0.01%	669
2014 Q4	$22K	Hold	350	–	–	﹤0.01%	740
2014 Q3	$21K	Hold	350	–	–	﹤0.01%	758
2014 Q2	$19K	Hold	350	–	–	﹤0.01%	747
2014 Q1	$21K	Hold	350	–	–	﹤0.01%	742
2013 Q4	$19K	Hold	350	–	–	﹤0.01%	748
2013 Q3	$16K	Hold	350	–	–	﹤0.01%	739
2013 Q2	$14K	Buy	+350	New	+$15K	﹤0.01%	723

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Private Bank & Trust's CRL Position: Q1 2015 in Review

Boston Private Bank & Trust held its Charles River Laboratories (CRL) position steady in Q1 2015 at 350 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #669.

Boston Private Bank & Trust first reported a position in CRL in Q2 2013 and has held it in 8 quarters since. 259 funds tracked by Wall St. Rank hold CRL as of Q1 2015.

Boston Private Bank & Trust held 350 shares of Charles River Laboratories worth $28K as of Q1 2015.
Boston Private Bank & Trust left its Charles River Laboratories share count unchanged in Q1 2015.
Charles River Laboratories made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #669 holding.
Boston Private Bank & Trust first reported a position in Charles River Laboratories in Q2 2013 and has held it in 8 quarters since.
259 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.